Media Release: 91Ƭ to receive prestigious research chair on cancer and chronic disease
November 16, 2023
Share
KINGSTON – The Government of Canada has announced the appointment of 34 new Canada Excellence Research Chairs (CERC) at 18 post-secondary institutions across the country, including Queen 91Ƭ ’s.
Paul Kubes will join Queen 91Ƭ ’s Health Sciences and the Queen 91Ƭ ’s Cancer Research Institute as the Canada Excellence Research Chair in Immunophysiology and Immunotherapy. Dr. Kubes is among the CERCs receiving $8 million over eight years to support his research, as announced by the Honourable Terry Beech, Minister of Citizens’ Services on behalf of Minister François-Philippe Champagne of Innovation, Science and Industry, at Simon Fraser University.
“It is an unbelievable honour to have received a CERC and be part of this incredibly important program that allows researchers to explore the biggest challenges facing humans,” says Dr. Kubes. “With Queen 91Ƭ ’s longstanding expertise and talented researchers in cancer biology and clinical trials, inflammation, and immunotherapy, I know there will be exciting opportunities to make a real difference in the lives of patients.”
Dr. Kubes’ research program is at the forefront of real-time imaging of the immune system. Changes in a person 91Ƭ ’s immune cell biology can alter the stability of the body 91Ƭ ’s chemical and physical state leading to disease. Understanding how and why these changes occur to our stable state can help to decipher the complex immune pathways involved in cancer, infection, and chronic disease.
“We’re proud to have secured another Canada Excellence Research Chair and thrilled to be welcoming Dr. Kubes to Queen 91Ƭ ’s,” says Nancy Ross, Vice Principal (Research). “His world-class research program will complement and bolster existing research strengths at the university, focused on solving global human health challenges.”
An internationally renowned expert in immunology, Kubes previously held the Canada Research Chair in Leukocyte Recruitment in Inflammatory Disease. He was also the Founding Director of the Snyder Institute for Chronic Diseases at the University of Calgary and is a Queen 91Ƭ ’s alumnus.
“Science and research are the driving forces of innovation. Today 91Ƭ ’s investments in elite researchers and their innovations will have lasting impacts across our academic sector, economy and society, all while building the foundation for a more sustainable and competitive Canada.” says François-Philippe Champagne, Minister of Innovation, Science and Industry. “These new Canada Excellence Research Chairs will work with our postsecondary institutions to tackle some of the world 91Ƭ ’s most complex challenges and make Canada a leader on the global stage.”
Launched in 2008, the CERC program is a tri-agency initiative that supports universities in their efforts to build on Canada 91Ƭ ’s growing reputation as a global leader in research and innovation. The program awards world-renowned researchers and their teams either $8 million or $4 million to establish research programs at Canadian universities.
Dr. Kubes will begin his term at Queen 91Ƭ ’s in Spring 2024. To learn more about Dr. Kubes’ research, read his interview with the Queen 91Ƭ ’s Gazette, and visit the to learn more about the recently appointed CERCs.
-30-
Media Contacts
Mitchell Fox
Media Relations Officer
Mitchell.fox@queensu.ca
343-363-1794